-
1
المؤلفون: Funda Meric-Bernstam, Jenny C. Chang, Ya-Chen T. Shih, Ying Xu, Yan Xing
المصدر: Journal of Clinical Oncology. 35:e18016-e18016
مصطلحات موضوعية: Oncology, Cancer Research, medicine.medical_specialty, Everolimus, business.industry, Cancer, Discovery and development of mTOR inhibitors, medicine.disease, Cancer treatment, Second line, Non elderly, Internal medicine, medicine, Medical prescription, Private insurance, business, medicine.drug
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::8b3580ca3448aaa1b7251c55bd0138d6Test
https://doi.org/10.1200/jco.2017.35.15_suppl.e18016Test -
2
المؤلفون: Shenhong Wu, Anu Radha Neerukonda, Shiney Koshy
المصدر: Journal of Clinical Oncology. 32:e13534-e13534
مصطلحات موضوعية: Oncology, Cancer Research, medicine.medical_specialty, Everolimus, business.industry, Anemia, Cancer, macromolecular substances, medicine.disease, Discovery and development of mTOR inhibitors, Temsirolimus, law.invention, Randomized controlled trial, law, Meta-analysis, Internal medicine, medicine, business, PI3K/AKT/mTOR pathway, medicine.drug
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::0a83521ed357a0ace02e1951f03e46c1Test
https://doi.org/10.1200/jco.2014.32.15_suppl.e13534Test -
3
المؤلفون: Shenhong Wu, Christine Ann Garcia
المصدر: Journal of Clinical Oncology. 32:2604-2604
مصطلحات موضوعية: Oncology, Cancer Research, medicine.medical_specialty, Everolimus, business.industry, Cancer, Serious infection, medicine.disease, Discovery and development of mTOR inhibitors, Temsirolimus, law.invention, Randomized controlled trial, law, Meta-analysis, Internal medicine, medicine, business, PI3K/AKT/mTOR pathway, medicine.drug
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::062345a29e496741e356eb1aafd14053Test
https://doi.org/10.1200/jco.2014.32.15_suppl.2604Test -
4
المؤلفون: Vivek Subbiah, Siqing Fu, Xiaochun Liu, Ralph Zinner, Jessica N. Williams, David S. Hong, Razelle Kurzrock, Sarina Anne Piha-Paul, Robert A. Wolff, Lacey McQuinn, Jennifer J. Wheler, Gerald S. Falchook, Filip Janku, Apostolia Maria Tsimberidou, Aung Naing, Daniel D. Karp
المصدر: Journal of Clinical Oncology. 31:e13575-e13575
مصطلحات موضوعية: Oncology, Cancer Research, medicine.medical_specialty, Treatment response, Side effect, business.industry, Incidence (epidemiology), Cancer, Pharmacology, medicine.disease, Discovery and development of mTOR inhibitors, Temsirolimus, Internal medicine, medicine, Mucositis, In patient, business, medicine.drug
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::9ac492aeb92151e05d1a8df070bc7028Test
https://doi.org/10.1200/jco.2013.31.15_suppl.e13575Test -
5Risk of pneumonitis with mammalian target of rapamycin (mTOR) inhibitors everolimus and temsirolimus
المؤلفون: Vishal Navnitray Ranpura, Shenhong Wu
المصدر: Journal of Clinical Oncology. 31:e13573-e13573
مصطلحات موضوعية: Oncology, Cancer Research, medicine.medical_specialty, Everolimus, business.industry, Cancer, medicine.disease, Discovery and development of mTOR inhibitors, Temsirolimus, Clinical trial, Internal medicine, Medicine, business, medicine.drug, Pneumonitis
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::ffe286bae0ea969491761bcf14bd73b4Test
https://doi.org/10.1200/jco.2013.31.15_suppl.e13573Test -
6
المؤلفون: Martin H. Voss, Christoph A. Karlo, Ana M. Molina, Sujata Patil, Robert J. Motzer, Darren R. Feldman, Diogo Assed Bastos, Albulena Ajeti
المصدر: Journal of Clinical Oncology. 31:450-450
مصطلحات موضوعية: Oncology, Cancer Research, medicine.medical_specialty, Pathology, Poor prognosis, Everolimus, business.industry, Cancer, Aggressive phenotype, medicine.disease, Discovery and development of mTOR inhibitors, Temsirolimus, Clear cell renal cell carcinoma, Internal medicine, medicine, In patient, business, medicine.drug
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::adf4fd434ac040213805c05ae610c6e2Test
https://doi.org/10.1200/jco.2013.31.6_suppl.450Test -
7
المؤلفون: Sagar Lonial, Chunzi Huang, Bassel F. El-Rayes, Wayne Harris, John S. Kauh, David H. Lawson, Dong M. Shin, Mohammed S Hossain, Zhengjia Chen, Natalyn Hawk, A. Akintayo, Suresh S. Ramalingam, Nabil F. Saba, A. Rene Merriewether, R. Donald Harvey, Colleen Lewis, Taofeek K. Owonikoko, Edmund K. Waller, Fadlo R. Khuri
المصدر: Publons
مصطلحات موضوعية: Cancer Research, Everolimus, business.industry, Cancer, Discovery and development of mTOR inhibitors, medicine.disease, Phase i study, Oncology, Pharmacodynamics, Cancer research, Medicine, In patient, business, Cytotoxicity, medicine.drug, Lenalidomide
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e4ad84fdbe640ae850b46055d63441ceTest
https://doi.org/10.1200/jco.2012.30.15_suppl.2576Test -
8
المؤلفون: D.J. Richel, Heinz-Josef Klümpen, J.H.M. Schellens, Johanna W. Wilmink, J. H. Beijnen, R. Sparidans, Maarten J. Deenen
المصدر: Journal of Clinical Oncology. 28:2557-2557
مصطلحات موضوعية: Oncology, Cancer Research, medicine.medical_specialty, Everolimus, business.industry, Cancer, Discovery and development of mTOR inhibitors, medicine.disease, Capecitabine, Pharmacokinetics, Internal medicine, medicine, In patient, business, PI3K/AKT/mTOR pathway, medicine.drug
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::8c2e96a09e4aa8e500afcc3f85fe5706Test
https://doi.org/10.1200/jco.2010.28.15_suppl.2557Test -
9
المؤلفون: Patrick A. Singleton, Jonathan Moss, Joe G.N. Garcia
المصدر: Journal of Clinical Oncology. 27:e14636-e14636
مصطلحات موضوعية: Cancer Research, business.industry, Angiogenesis, Cancer, Discovery and development of mTOR inhibitors, medicine.disease, Methylnaltrexone, Temsirolimus, Metastasis, Oncology, Cancer research, Medicine, Tumor growth, business, medicine.drug
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::67a5c573682148b977bd285ae8c3c4e3Test
https://doi.org/10.1200/jco.2009.27.15_suppl.e14636Test